Position in LEGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$242,303
+$104,602 QoQ
Shares Held
8,390
+10.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#156
of 218 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LEGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026KBC Group NV holds $308,329,109 across 107 Biotechnology names. LEGN ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
179,508 | $111,930,417 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
128,466 | $63,812,914 | |
| 3 | INCY |
Incyte Corp
|
270,882 | $30,707,183 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
98,265 | $23,678,916 | |
| 5 | CORT |
Corcept Therapeutics Inc
|
91,584 | $7,963,228 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
129,010 | $7,787,043 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
127,194 | $7,278,040 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
116,847 | $6,372,835 |
All Filings in LEGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $242,303 | 8,390 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $137,701 | 7,612 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $424,234 | 19,514 | Shares | Defined | 2026-01-26 | |
| 2025-09-30 | $636,351 | 19,514 | Shares | Defined | 2026-01-20 | |
| 2025-06-30 | $606,275 | 17,083 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $917,738 | 27,048 | Shares | Defined | 2025-04-25 | |
| 2024-12-31 | $427,705 | 13,144 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $640,507 | 13,144 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $582,147 | 13,144 | Shares | Defined | 2024-07-17 | |
| 2024-03-31 | $737,246 | 13,144 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $958,568 | 15,931 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,035,022 | 15,409 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $1,128,709 | 16,351 | Shares | Defined | 2024-02-15 | |
| 2023-03-31 | $836,665 | 17,351 | Shares | Defined | 2024-02-14 | |
| 2022-12-31 | $926,065 | 18,551 | Shares | Defined | 2024-02-14 | |
| 2022-09-30 | $842,887 | 20,659 | Shares | Defined | 2024-02-15 | |
| 2022-06-30 | $1,208,240 | 21,968 | Shares | Defined | 2024-02-14 | |
| 2022-03-31 | $1,194,314 | 32,865 | Shares | Defined | 2024-02-14 | |
| 2021-12-31 | $1,203,936 | 25,830 | Shares | Defined | 2024-02-14 | |
| 2021-09-30 | $1,017,671 | 20,128 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $1,118,776 | 27,254 | Shares | Defined | 2022-02-15 | |
| 2021-03-31 | $790,911 | 27,254 | Shares | Defined | 2022-02-14 | |
| 2020-12-31 | $615,831 | 21,869 | Shares | Defined | 2022-02-14 | |
| 2020-09-30 | $2,073,413 | 67,166 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||